Addiction, stress and the brain: a primer for counselors

Glowing amber and blue filaments branching against a dark blue background.

Reward, learning, and cues

The National Institute on Drug Abuse (NIDA) defines addiction as a chronic, relapsing disorder in which seeking and using a drug can become compulsive despite harmful consequences[1]. Its account places reward alongside stress and self-control because addiction involves functional differences across all of those circuits[1]. NIDA also describes biological and environmental factors that affect vulnerability, with a varying balance of risk and protection from person to person[1].

In NIDA’s explanation of brain signaling, a neuron can release a chemical messenger, or neurotransmitter, into the space between cells, where it binds to receptors on the receiving cell[2]. Dopamine is one of those messengers in that account[2]. NIDA describes a dopamine signal during a rewarding experience as part of the learning that makes a behavior easier to repeat and form into a habit[2]. The agency distinguishes that reinforcing role from the immediate experience of euphoria, which it describes as incompletely understood and likely to involve several kinds of chemical signaling[2].

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) identifies a pathway from the ventral tegmental area to the nucleus accumbens in its account of alcohol reward learning[3]. In that account, incentive salience means the motivational pull a reward and its cues acquire through learning, with the strength of that pull also influenced by a person’s current physiological state[3]. NIDA notes that reminders in the environment can elicit craving even when the drug is unavailable[2]. The glossary entry on the reward system puts reinforcement and incentive salience in the wider vocabulary of learning.

NIDA distinguishes the duration of a signal from the persistence of learned associations. Transporter molecules help end some messages between neurons by taking chemical messengers back into the cell that released them[2]. In the agency’s account of cue learning, the association with prior use can persist long after the original experience[2]. NIDA also describes reduced reward sensitivity with repeated exposure and calls a reduced response to a familiar level of exposure tolerance[2][4].

The alcohol addiction cycle

NIAAA describes a three-stage model in which each stage feeds into the others and a person can enter the cycle at any stage[5]. The agency’s neuroscience overview situates the model at the moderate to severe end of alcohol use disorder and associates each stage with a principal set of circuits[3].

For NIAAA, the time over which the sequence unfolds can vary from multiple repetitions in a day to a progression over weeks or months[5]. Its neuroscience overview describes differences in the prominence of reward seeking and relief seeking, including when people are first drawn to alcohol[3].

Binge / intoxication Withdrawal / negative affect Preoccupation / anticipation

Binge and intoxication

NIAAA associates binge and intoxication with circuits in the basal ganglia, a collection of structures involved in reward, motivation, and habit formation[3][5]. The agency describes positive reinforcement in this stage as the contribution of rewarding effects to repeated drinking[5]. In its account of habit formation, repeated patterns of drinking become less dependent on deliberate control and increasingly involve the basal ganglia circuits associated with habits[3].

Withdrawal and negative affect

For withdrawal and negative affect, NIAAA emphasizes the extended amygdala and increased activity in stress circuits alongside reduced reward activity[3]. The agency describes unpleasant emotional states including irritability, anxiety, and dysphoria, or marked emotional distress, as well as physical features such as pain and disturbed sleep[5]. In this stage, NIAAA describes negative reinforcement as a shift in motivation toward temporary relief from discomfort associated with withdrawal[3]. The agency uses hyperkatifeia for heightened negative emotion during withdrawal and describes its role in motivating drinking for relief as a hypothesis[5].

Preoccupation and anticipation

NIAAA associates preoccupation and anticipation with the prefrontal cortex and the executive functions that support impulse control, planning, and decisions[5][3]. During this stage, the agency describes urges to drink in relation to stress, associated negative emotion, and previously learned reminders of alcohol[3]. Its neuroscience summary describes a connection from the prefrontal cortex to the basal ganglia that uses glutamate and can participate in renewed alcohol seeking in response to cues[3].

A 2016 neurocircuitry review discusses signaling from the prefrontal cortex and the insula to both the basal ganglia and extended amygdala in relation to craving and executive function[6]. Its focus on connections among regions complements NIAAA’s single-region labels for the principal circuits at each stage[5].

Stress physiology and cumulative load

The National Institute of Mental Health (NIMH) describes stress as a mental or physical response to an external demand, which may occur briefly or recur over a long period[7]. At the physiological level, the hypothalamic–pituitary–adrenal axis, or HPA axis, is a network of hormonal signals among the hypothalamus, the pituitary gland below it, and the adrenal glands above the kidneys[8]. The autonomic nervous system contributes to the bodily stress response through pathways that include rapid activation of sympathetic activity in immediate adaptation[9].

In the HPA pathway, the hypothalamus produces corticotropin-releasing hormone, which helps signal the anterior pituitary gland to release adrenocorticotropic hormone, or ACTH[8]. ACTH prompts the adrenal cortex to release hormones including cortisol[8]. Cortisol also signals back to the hypothalamus and pituitary to restrain activity in the pathway, an example of negative feedback[8]. The HPA reference describes variations in that signaling in relation to sleep and waking, physical activity, illness, and stress[8].

Allostasis is the maintenance of stability through adjustment under changing demands, as discussed in the published allostatic review[10]. Allostatic load is the cumulative physiological burden associated with repeated or sustained activation of stress responses[11]. The allostatic load reference describes persistent activity across hormonal, cardiovascular, and emotional systems and treats the term as a description of accumulated effects across those systems[11].

Studies of allostatic load often combine physiological indicators across systems in a composite index[11]. The reference notes that studies select different indicators and use different methods to combine them, so the index used in a particular study matters to how its results are interpreted[11].

What reviews report about stress and relapse

Separate strands of review evidence address exposure to stress, physiological responses, and return to substance use. A 2007 review found that human laboratory and imaging findings on stress and craving were consistent with clinical observations of relapse vulnerability, and discussed differences in stress responses between people with alcohol addiction and a matched group of social drinkers[12]. The review describes converging observations and offers stress-pathway changes as a possible explanation for the relationship[12].

A 2008 review described population studies that identified stressors and individual characteristics predictive of substance use, alongside experiments reporting increased drug seeking after stress exposure in animals already exposed to a drug[13]. Its discussion of early adversity and accumulated stress treats changes in stress and learning systems as candidate mechanisms and identifies unanswered questions about their relationship to addiction[13].

A 2019 review focused mainly on human research on acute hormonal and autonomic responses, comparing evidence in people with light or little use and people with heavy or chronic use[14]. It examined shifts in baseline activity and in short-term responses alongside cue reactivity and craving, and flagged differences in methods, histories of drug use, exposure to early adversity, and co-occurring drug use as influences on interpretation[14].

The 2024 review described an adaptive stress response in terms of a baseline, an acute reaction, and a return toward physiological balance[15]. It discussed disruptions at different points in that response and their links with craving and relapse risk, including evidence across subjective experience, cognition, and biological measures[15]. The review presented a framework for connecting findings across those levels and considered implications for intervention development[15].

Allostatic models of addiction

A 2001 review proposed an allostatic account of persistent vulnerability to relapse after drug use has ceased[16]. In that model, reward regulation can settle outside its usual range, with stress responses helping to sustain the deviation[16]. The review describes recruitment of circuits involved in compulsive behavior as a proposed explanation for loss of control[16].

A 2019 allostatic review argued that stress could act across the addiction cycle through alterations in signaling involving corticotropin-releasing factor, a chemical messenger involved in stress responses[10]. The argument treats repeated demands on emotional regulation as a mechanism and discusses the load within an animal-based account of motivational circuitry[10].

A separate 2019 integrative review interpreted human neurobiological literature in terms of cumulative stress load, craving, and greater vulnerability to relapse[17]. That account was a narrative synthesis drawing on frequently cited articles and related references, and its authors emphasized the social context surrounding the brain and behavior relationships they discussed[17].

Neuroplasticity and recovery

The reference term neuroplasticity refers to the capacity of neural networks to change their connections and organization through experience, including in adulthood[18]. NIAAA uses the term in discussing both the development of alcohol use disorder and changes observed during recovery[3]. It reports evidence of some improvements in behavior and brain function during abstinence and describes possible compensation by other circuits when changes persist[3]. The degree to which function returns over time remains uncertain in the agency’s account[3].

NIDA describes addiction as a treatable chronic condition and recovery in terms of a return to productive life[19]. In its discussion of chronic illness, the agency explains why a return to use can occur in recovery and why that event alone does not establish treatment failure[19]. This distinction is part of the professional vocabulary for a counseling conversation about the course of recovery. The handbook’s section on recovery and relapse prevention places that vocabulary alongside other addiction counseling subjects.

Sources used on this page

  1. Drug Misuse and Addiction | National Institute on Drug Abuse (NIDA)
  2. : Drugs and the Brain | NIDA
  3. Neuroscience: The Brain in Addiction and Recovery | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  4. Drug tolerance - Wikipedia
  5. The Cycle of Alcohol Addiction | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  6. Neurobiology of addiction: a neurocircuitry analysis (2016)
  7. I’m So Stressed Out! Fact Sheet - National Institute of Mental Health (NIMH)
  8. Hypothalamic–pituitary–adrenal axis - Wikipedia
  9. Stress (biology) - Wikipedia
  10. Addiction and stress: An allostatic view (2019)
  11. Allostatic load - Wikipedia
  12. The role of stress in addiction relapse (2007)
  13. Chronic stress, drug use, and vulnerability to addiction (2008)
  14. Drug-induced stress responses and addiction risk and relapse (2019)
  15. Stress and substance use disorders: risk, relapse, and treatment outcomes (2024)
  16. Drug addiction, dysregulation of reward, and allostasis (2001)
  17. The role of stress in drug addiction. An integrative review (2019)
  18. Neuroplasticity - Wikipedia
  19. Treatment and Recovery | National Institute on Drug Abuse (NIDA)